Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_assertion type Assertion NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_head.
- NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_assertion description "[In chronic-phase PMF, JAK2 46/1 haplotype nullizygosity (P<0.01; hazard ratio (HR) 2.9, 95% confidence interval (CI) 1.7-5.2), but not IDH mutational status (P=0.55; HR 1.3, 95% CI 0.5-3.4), had an adverse effect on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_provenance.
- NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_assertion evidence source_evidence_literature NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_provenance.
- NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_assertion SIO_000772 20508616 NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_provenance.
- NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_assertion wasDerivedFrom befree-20140225 NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_provenance.
- NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_assertion wasGeneratedBy ECO_0000203 NP926148.RAnM1RfcF4HqCXVE2KeBkgoBFsFLPuqSTJDPIZzXMDpnk130_provenance.